Logo image
Endothelium-specific gene and stem cell-based therapy for erectile dysfunction
Journal article   Open access   Peer reviewed

Endothelium-specific gene and stem cell-based therapy for erectile dysfunction

Travis D Strong, Milena A Gebska, Arthur L Burnett, Hunter C Champion and Trinity J Bivalacqua
Asian journal of andrology, Vol.10(1), pp.14-22
01/2008
DOI: 10.1111/j.1745-7262.2008.00362.x
PMID: 18087639
url
https://doi.org/10.1111/j.1745-7262.2008.00362.xView
Published (Version of record) Open Access

Abstract

Erectile dysfunction (ED) commonly results from endothelial dysfunction of the systemic vasculature. Although phosphodiesterase type 5 (PDE-5) inhibitors are effective at treating most cases of ED, they must be taken routinely and are ineffectual for a meaningful number of men. In recent years gene and stem cell-based therapies targeted at the penile endothelium have been gaining momentum in preclinical studies. These early studies reveal that gene and stem cell-based therapies may be both enduring and efficacious, and may eventually lead to a cure for ED. The following review will highlight our current understanding of endothelial-specific gene and stem cell-based therapies performed to date in a number of experimental animal models.
Genetic Therapy Superoxide Dismutase - genetics Endothelial Cells Humans Male Vascular Endothelial Growth Factor A - genetics Nitric Oxide Synthase Type III - genetics Stem Cell Transplantation Animals Erectile Dysfunction - therapy Multipotent Stem Cells - transplantation Cell Differentiation Endothelium, Vascular

Details

Metrics

Logo image